Show simple item record

dc.contributor.author Haeryfar, Seyed Mohammad Mansour en_US
dc.date.accessioned 2007-05-18T20:00:14Z
dc.date.available 2007-05-18T20:00:14Z
dc.date.issued 1999-08-01T00:00:00Z en_US
dc.identifier.uri http://hdl.handle.net/1993/1833
dc.description.abstract Antiestrogenic drugs tamoxifen (TX) and toremifene (TO) are known to augment immune cytolysis in tumor targets induced by various killer cells. Here, we show that antiestrogens are capable of enhancing natural killer (NK) cell-mediated cytotoxicity against K562 erythroleukemia cell line and that both target and effector cells should be treated with antiestrogens in order for the maximal lysis to be achieved. K562 cells are Fas (CD95/Apo-1)-negative and treatment with antiestrogens had no influence on Fas expression. The presence of the Ca++ chelator EGTA/MgCl2 in the cytotoxicity assay totally abrogated K562 cytolysis and its antiestrogen-mediated augmentation, suggesting the involvement of the perforin/granzyme pathway. Treatment of K562 with the general caspase inhibitor zVAD-fmk did not inhibit specific cytotoxicity, indicating the caspase-independent nature of K562 immune cytolysis. When interleukin-2 (IL-2)-activated killer cells were subjected to antiestrogen pretreatment before being used against K562, cytotoxicity was significantly inhibited. In conclusion, antiestrogens, can affect the perforin/granzyme pathway of killer cell-mediated oncolysis. en_US
dc.format.extent 4449884 bytes
dc.format.extent 184 bytes
dc.format.mimetype application/pdf
dc.format.mimetype text/plain
dc.language en en_US
dc.language.iso en_US
dc.title Antiestrogens modulate the perforin/granzyme pathway of natural killer cell-mediated cytolysis en_US
dc.degree.discipline Immunology en_US
dc.degree.level Master of Science (M.Sc.) en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

View Statistics